Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Ruinuo Medical Technology is a medical device company specializing in the development and manufacturing of high-end consumables for minimally invasive cardiovascular and peripheral vascular interventions. Founded in 2015 and headquartered in Shanghai, the company offers a range of products including PTCA balloon dilatation catheters, high-pressure balloons, and peripheral balloons, many of which have received NMPA and CE certifications. Ruinuo Medical focuses on providing high-quality, cost-effective interventional solutions to address the growing demand for vascular disease treatments. The company is backed by prominent venture capital firms such as Sequoia China and continues to expand its portfolio into innovative areas like drug-coated balloons.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ruinuo Medical Technology.